Sabra Health Care REIT, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Available to Common Stockholders, Basic $60.0m
$148.1m +146.76%
$269.3m +81.80%
$69.0m -74.38%
$138.4m +100.62%
($77.6m)
$13.8m +117.73%
$126.7m +821.14%
$155.6m +22.81%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $70.3m $158.4m $279.1m $69.0m $138.4m ($113.3m) ($77.6m) $13.8m $126.7m $155.5m
Net Income (Loss) Attributable to Noncontrolling Interest ($71k) ($18k) $33k $22k $0 $0 ($99k)
Depreciation, Depletion and Amortization $68.5m $113.9m $191.4m $181.5m $176.7m $179.0m $187.8m $183.1m $169.6m $187.0m $209.4m
Amortization of Debt Issuance Costs $5.0m
Amortization of Debt Issuance Costs and Discounts $7.8m $10.1m $10.1m $8.4m $8.4m $11.1m $12.3m $10.5m $8.0m
Amortization of Intangible Assets $8.7m $17.6m $11.6m $7.5m $19.1m
Depreciation Amortization Depletion $187.8m $183.1m $169.6m $187.0m $209.4m
Share-based Payment Arrangement, Noncash Expense $7.5m $8.4m $7.6m $9.8m $7.9m $7.9m $7.5m $7.9m $9.0m $11.4m $13.1m
Payment, Tax Withholding, Share-based Payment Arrangement $1.5m $3.1m $400k $1.5m $3.2m $2.1m $3.3m $1.8m $2.6m $5.5m
Equity Method Investment, Other than Temporary Impairment $164.1m $57.8m $0 $0
Asset Impairment Charge $151.8m $14.3m $18.5m $7.3m $3.7m
Income (Loss) from Equity Method Investments ($5.4m) ($6.8m) ($16.6m) ($28.0m) ($40.3m) ($2.9m) ($397k) $3.9m
Other Nonoperating Income (Expense) $54.6m $129.8m ($11.9m) $4.5m ($21.9m) ($13.5m) ($75.6m) $4.8m $9.4m
Earnings (Loss)es From Equity Investments $40.3m $2.9m $397k ($3.9m) ($7.0m)
Change In Working Capital ($19.7m) ($2.7m) ($22.5m) ($9.9m) ($8.7m)
Change In Receivables ($6.4m) ($11.1m) ($15.5m) ($11.4m) ($16.5m)
Changes In Account Receivables ($6.4m) ($11.1m) ($15.5m) ($11.4m) ($16.5m)
Change In Payables And Accrued Expense ($13.2m) $8.3m ($7.1m) $1.6m $7.8m
Other Operating Income (Expense), Net $10.7m $3.2m $4.5m $2.1m $2.2m $373k ($1.1m) $2.6m $2.7m $14.0m
Net Cash Provided by (Used in) Operating Activities $176.7m
$133.5m -24.47%
$358.5m +168.60%
$372.5m +3.89%
$354.9m -4.73%
$356.4m +0.43%
$315.7m -11.41%
$300.6m -4.80%
$310.5m +3.32%
$348.6m +12.26%
$371.6m +6.59%
Cash flows from investing activities:
Payments to Acquire Investments $7.3m $2.7m $5.3m $0 ($669k)
Payments for (Proceeds from) Other Investing Activities $0
Net Other Investing Changes ($19.3m) $3.7m ($15.7m) $15.3m $214.2m
Net Cash Provided by (Used in) Investing Activities $142.4m ($240.1m) ($258.5m) $262.8m ($136.5m) ($336.2m) ($216.2m) $103.1m ($109.0m) ($378.0m) ($335.0m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($556k) ($553k) ($2.9m) ($16.3m) ($531k) ($34.6m) ($411k) ($1.5m) $0 ($1.2m)
Issuance Of Debt $204.0m $12.2m $14.6m $609.8m $655.5m
Long Term Debt Issuance $204.0m $12.2m $14.6m $609.8m $655.5m
Long Term Debt Payments ($81.3m) ($106.3m) ($2.0m) ($502.1m) ($502.1m)
Net Issuance Payments Of Debt $122.8m ($94.1m) $12.6m $107.7m $153.3m
Net Long Term Debt Issuance $122.8m ($94.1m) $12.6m $107.7m $153.3m
Net Short Term Debt Issuance $0 $204.0m
Repayment Of Debt ($81.3m) ($106.3m) ($2.0m) ($502.1m) ($502.1m)
Proceeds from Issuance of Common Stock ($1.3m) $366.8m $227.8m
Common Stock Dividend Paid ($277.2m) ($277.4m) ($280.1m) ($289.5m) ($298.1m)
Common Stock Issuance $308.7m ($4.8m) ($2.7m) $86.1m $227.8m $227.8m
Common Stock Payments ($4.8m) ($2.7m)
Issuance Of Capital Stock $308.7m $86.1m $227.8m $227.8m
Repurchase Of Capital Stock ($4.8m) ($2.7m)
Dividends paid $119.3m $182.1m $325.2m $335.4m $278.3m $262.9m $277.2m $277.4m $280.1m $289.5m ($298.1m)
Cash Dividends Paid ($277.2m) ($277.4m) ($280.1m) ($289.5m) ($298.1m)
Dividend Received CFO $0 $3.5m $5.4m $7.8m $8.0m
Dividends Received CFI $0 $544k $0 $6.8m $6.8m
Proceeds from (Payments for) Other Financing Activities $0 $0 $0 $0
Net Other Financing Charges ($2.5m) ($36.0m) ($94k) ($5.2m) ($6.5m)
Net Cash Provided by (Used in) Financing Activities ($300.9m)
$598.8m +299.01%
($627.3m) -204.76%
($646.2m) -3.01%
($202.1m) +68.72%
$30.1m +114.91%
($161.7m) -636.52%
($410.3m) -153.73%
($181.6m) +55.75%
$40.8m +122.45%
$100.0m +145.39%
Beginning Cash Position $115.9m $53.9m $46.7m $66.3m $101.7m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.7m $49.1m $65.5m $115.9m $53.9m $46.7m $66.3m $78.1m $238.3m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($539k) $346k $88k $29k $268k ($614k) ($359k) $391k $75k
Effect Of Exchange Rate Changes $268k ($614k) ($359k) $391k $75k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Payments of Financing Costs $5.9m $15.3m $352k $15.6m $830k $9.3m $20k $18.1m $94k $4.4m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $137.7m $123.9m $92.6m $85.5m $97.7m $102.4m $105.2m $111.0m
Additional Financial Items
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $11.3m ($12.0m) ($76.6m) $2.1m
Gain (Loss) on Termination of Lease $10.6m $0 $0
Gains (Losses) on Sales of Investment Real Estate ($6.1m) $52.0m $128.2m $2.3m $2.9m $12.3m ($12.0m) ($76.6m) $2.1m ($3.5m)
General and Administrative Expense $19.9m $32.4m $36.5m $30.5m $32.8m $34.7m $39.6m $47.5m $50.1m $53.7m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $70.2m $158.4m $279.1m $69.0m $138.4m
Income Tax Expense (Benefit) $651k $3.0m $3.4m $710k $1.8m $1.2m $2.0m $1.0m $1.8m
Operating Costs and Expenses $5.7m $17.9m $49.5m
Operating Lease, Expense $1.4m $1.3m $1.0m
Operating Lease, Lease Income $452.1m $430.6m $396.7m $400.6m $376.3m $381.5m $374.1m
Proceeds from Contributions from Parent $0
Proceeds from Noncontrolling Interests $0 $0 $2.0m
Cash Flow From Continuing Financing Activities ($161.7m) ($410.3m) ($181.6m) $40.8m $100.0m
Cash Flow From Continuing Investing Activities ($216.2m) $103.1m ($109.0m) ($378.0m) ($335.0m)
Change In Cash Supplemental As Reported ($62.2m) ($6.6m) $20.0m $11.4m
Changes In Cash ($62.2m) ($6.6m) $20.0m $11.4m $136.6m
End Cash Position $53.9m $46.7m $66.3m $78.1m $238.3m
Financing Cash Flow ($161.7m)
($410.3m) -153.73%
($181.6m) +55.75%
$40.8m +122.45%
$100.0m +145.39%
Free Cash Flow $315.7m $300.6m $310.5m $348.6m $371.6m
Gain Loss On Investment Securities $12.0m $76.6m ($2.1m) $3.5m ($24.2m)
Income Tax Paid Supplemental Data $1.7m $1.7m $1.4m $1.5m $1.5m
Investing Cash Flow ($216.2m) $103.1m ($109.0m) ($378.0m) ($335.0m)
Net Business Purchase And Sale ($142.9m) ($5.2m) ($1.3m) ($1.2m) $0
Net Investment Properties Purchase And Sale ($51.4m) $109.7m ($95.1m) ($405.8m) ($558.8m)
Net Investment Purchase And Sale ($2.6m) ($5.6m) $3.1m $7.0m $2.8m
Operating Gains Losses $52.7m $81.1m ($1.7m) $745k ($30.1m)
Other Non Cash Items $13.2m ($510k) $6.1m ($10.2m)
Provisionand Write Offof Assets $141k $191k ($571k) ($1.0m) $101.6m
Purchase Of Business ($142.9m) ($5.2m) ($1.3m) ($1.2m) $0
Purchase Of Investment ($8.0m) ($11.0m) ($2.8m) ($9k) ($669k)
Purchase Of Investment Properties ($146.7m) ($163.4m) ($191.1m) ($494.5m) ($669k)
Sale Of Investment $5.4m $5.5m $5.9m $7.0m $3.5m
Sale Of Investment Properties $95.3m $273.1m $96.0m $88.6m $3.5m
Stock Based Compensation $7.5m $7.9m $9.0m $11.4m $13.1m